| scholarly article | Q13442814 |
| P2093 | author name string | Bo Shen | |
| Lin Gao | |||
| Hang Yin | |||
| Julie Chao | |||
| Lee Chao | |||
| Zhi-Rong Yang | |||
| Makoto Hagiwara | |||
| P2860 | cites work | Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways | Q45195875 |
| Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes | Q45275064 | ||
| Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction | Q46373231 | ||
| Assay method for myeloperoxidase in human polymorphonuclear leukocytes | Q53558668 | ||
| Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing | Q68145718 | ||
| Enzymatic activity of rat submandibular gland kallikrein released into blood | Q69827405 | ||
| Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats | Q73426702 | ||
| Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats | Q73762488 | ||
| Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process | Q73959872 | ||
| Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases | Q74352915 | ||
| Bioregulation of kinins: kallikreins, kininogens, and kininases | Q28209765 | ||
| Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo | Q34293330 | ||
| Kallikrein activates bradykinin B2 receptors in absence of kininogen | Q35160954 | ||
| Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation | Q35740783 | ||
| Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction | Q36121736 | ||
| Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling | Q36122863 | ||
| Kallikrein-induced uterine contraction independent of kinin formation | Q36374020 | ||
| Kinin receptor subtypes | Q36594461 | ||
| Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. | Q36707984 | ||
| Isozymes of rat urinary kallikrein | Q39267810 | ||
| Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase | Q40512506 | ||
| Molecular mechanism of kininogen deficiency in brown Norway Katholiek rats. | Q40525159 | ||
| Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors. | Q40665795 | ||
| Myocardial infarct size and ventricular function in rats | Q41488928 | ||
| A fluorometric assay for the measurement of nitrite in biological samples. | Q41526007 | ||
| Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents | Q41845983 | ||
| Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice | Q43441971 | ||
| Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation | Q43599368 | ||
| Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction | Q44201662 | ||
| Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer | Q45057032 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 715-720 | |
| P577 | publication date | 2008-09-02 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation | |
| P478 | volume | 52 |
| Q33615794 | A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor |
| Q33623829 | Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function |
| Q27348019 | Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1 |
| Q33783946 | Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation |
| Q45754059 | Bradykinin-forming components in Kuwaiti patients with type 2 diabetes |
| Q43279383 | Cardioprotective effect of ornitho-kinin in an anesthetized, open-chest chicken model of acute coronary occlusion |
| Q39248182 | Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. |
| Q35116618 | Exercise training can prevent cardiac hypertrophy induced by sympathetic hyperactivity with modulation of kallikrein-kinin pathway and angiogenesis. |
| Q37193691 | Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy |
| Q38240527 | Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases. |
| Q36295779 | Human Tissue Kallikrein Activity in Angiographically Documented Chronic Stable Coronary Artery Disease |
| Q61812872 | Human tissue kallikrein in the treatment of acute ischemic stroke |
| Q34171244 | Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. |
| Q37482205 | Hypertension and the bradykinin system |
| Q41752395 | Increased Age-Related Cardiac Dysfunction in Bradykinin B2 Receptor-Deficient Mice |
| Q36517193 | Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy |
| Q34357797 | Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling |
| Q28749408 | Kinin B1 Receptor Enhances the Oxidative Stress in a Rat Model of Insulin Resistance: Outcome in Hypertension, Allodynia and Metabolic Complications |
| Q34132504 | Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. |
| Q28078199 | Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy |
| Q35070827 | Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells |
| Q35664924 | Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors |
| Q28541677 | Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus |
| Q39367362 | Proteins secreted by embryonic stem cells activate cardiomyocytes through ligand binding pathways |
| Q99615238 | The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction |
| Q42977921 | The kallikrein-kinin system in experimental Chagas disease: a paradigm to investigate the impact of inflammatory edema on GPCR-mediated pathways of host cell invasion by Trypanosoma cruzi |
| Q37697813 | Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing |
| Q36682256 | Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. |
| Q35106408 | Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells |
| Q43060191 | Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway |
| Q38240525 | Tissue kallikrein-kinin therapy in hypertension and organ damage. |